Drug intelligence / Profile preview

Calzmax-D3

Development stage
Unknown
Lead developer
Sanivo Biotec
Modality
Small Molecules
Administration
Oral
01

Overview

Calzmax-D3 is an oral nutritional supplement marketed by Sanivo Biotec for the support of bone health. It is a fixed-dose combination containing calcium carbonate (equivalent to 500 mg of elemental calcium), magnesium (100 mg), vitamin D3 (cholecalciferol, 200 IU), and zinc (4 mg). Calcium and magnesium are essential minerals that provide structural integrity to the bone matrix, while zinc acts as a cofactor for enzymes involved in bone remodeling. Vitamin D3 enhances the intestinal absorption of calcium by binding to and activating the vitamin D receptor (VDR). Together, these components work synergistically to maintain bone mineral density and prevent bone-related disorders such as osteoporosis and osteomalacia.

Brand names
Calzmax-D3Calzmax-D-3Calzmax-D 3
Other names
calcium carbonate + cholecalciferol + magnesium + zinccalcium carbonate + magnesium + vitamin D3 + zinccalcium carbonate, magnesium, vitamin D3, zinc
02

Targets

CaSR (Extracellular calcium-sensing receptor)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Calzmax-D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calzmax-D3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call